Related references
Note: Only part of the references are listed.2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
Sarah K. Medeiros et al.
THROMBOSIS RESEARCH (2020)
Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms
J. Matthew Nicklas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation
Michal Zabczyk et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk
Michal Zabczyk et al.
SCIENTIFIC REPORTS (2020)
Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi
Shana A. Shaya et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome
Michal Zabczyk et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism
Sandra Mrozinska et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Improving fibrinolysis in venous thromboembolism: impact of fibrin structure
Anetta Undas et al.
EXPERT REVIEW OF HEMATOLOGY (2019)
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
Faizan Khan et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study
Maciej Wiktor Polak et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
Magdalena Pirog et al.
DISEASE MARKERS (2019)
Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients
Mariusz Wojcik et al.
THROMBOSIS RESEARCH (2019)
Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism
Robert W. Kupis et al.
SCIENTIFIC REPORTS (2019)
Mechanical and Biochemical Role of Fibrin Within a Venous Thrombus
Anirudh Chandrashekar et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2018)
An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH
M. Pieters et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome
Magdalena Celinska-Lowenhoff et al.
RHEUMATOLOGY (2018)
Pulmonary embolism
Menno V. Huisman et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity
R. L. R. Carter et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Incidence and risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a systematic review and meta-analysis of cohort studies
Meng Zhang et al.
JOURNAL OF THORACIC DISEASE (2018)
Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
Aneta Stachowicz et al.
SCIENTIFIC REPORTS (2018)
Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis
Sarah Goldman et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study
Joanna Cieslik et al.
BLOOD (2018)
Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy
Michal Zabczyk et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban
Agnieszka Janion-Sadowska et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women
Johannes J. Sidelmann et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism
Aneta Stachowicz et al.
CLINICAL PROTEOMICS (2017)
Endogenous fibrinolysis facilitates clot retraction in vivo
Andre L. Samson et al.
BLOOD (2017)
Global Burden of Thrombosis Epidemiologic Aspects
Aaron M. Wendelboe et al.
CIRCULATION RESEARCH (2016)
Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome
J. Siudut et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study
P. A. Kyrle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
The epidemiology of venous thromboembolism
John A. Heit et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Deep vein thrombosis and pulmonary embolism
Marcello Di Nisio et al.
LANCET (2016)
Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism
William B. Stubblefield et al.
PLOS ONE (2016)
Epidemiology of venous thromboembolism in the Framingham Heart Study
Marja K. Puurunen et al.
THROMBOSIS RESEARCH (2016)
Fibrinolysis and the control of blood coagulation
John C. Chapin et al.
BLOOD REVIEWS (2015)
Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study
K. Sundquist et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Basic mechanisms and regulation of fibrinolysis
C. Longstaff et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment
Imre Varju et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Vitamin K antagonists favourably modulate fibrin clot properties in patients with atrial fibrillation as early as after 3 days of treatment: Relation to coagulation factors and thrombin generation
Michal Zabczyk et al.
THROMBOSIS RESEARCH (2015)
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
Christophe Marti et al.
EUROPEAN HEART JOURNAL (2015)
Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism
Marissa R. Martinez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin
Douglas B. Cines et al.
BLOOD (2014)
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
N. van Es et al.
BLOOD (2014)
Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice
S. A. Siefert et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism
A. T. Obi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation
Magdalena Celinska-Loewenhoff et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Fibrinogen and red blood cells in venous thrombosis
Maria M. Aleman et al.
THROMBOSIS RESEARCH (2014)
Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome
Anna Vikerfors et al.
THROMBOSIS RESEARCH (2014)
Mechanical Stability and Fibrinolytic Resistance of Clots Containing Fibrin, DNA, and Histones
Colin Longstaff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure
James J. Marsh et al.
THROMBOSIS RESEARCH (2013)
Antithrombin-Independent Effects of Heparins on Fibrin Clot Nanostructure
Christelle Yeromonahos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
Marie-Luise von Bruehl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis
Jose A. Diaz et al.
JOURNAL OF VASCULAR SURGERY (2012)
Prediction of Recurrent Venous Thromboembolism by Clot Lysis Time: A Prospective Cohort Study
Ludwig Traby et al.
PLOS ONE (2012)
Altered fibrin clot properties are associated with residual vein obstruction: Effects of lipoprotein(a) and apolipoprotein(a) isoform
Anetta Undas et al.
THROMBOSIS RESEARCH (2012)
Fibrin clot properties in women heterozygous for factor V Leiden mutation: Effects of oral contraceptives
Marzena Krzek et al.
THROMBOSIS RESEARCH (2012)
Molecular Mechanisms Affecting Fibrin Structure and Stability
Susan T. Lord
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate*
Margareta Blomback et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor A Systematic Review
Alfonso Iorio et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Mirjam E. Meltzer et al.
BLOOD (2010)
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor
C. T. Ammollo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Risk assessment for recurrent venous thrombosis
Paul Alexander Kyrle et al.
LANCET (2010)
High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension
Timothy A. Morris et al.
BLOOD (2009)
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives
Anetta Undas et al.
BLOOD (2009)
Mechanisms of venous thrombosis and resolution
Thomas W. Wakefield et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis
Mirjam E. Meltzer et al.
PLOS MEDICINE (2008)
Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis
Veronica C. Ardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Paolo Prandoni et al.
HAEMATOLOGICA (2007)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Epidemiology and risk factors for venous thrombosis
Mary Cushman
SEMINARS IN HEMATOLOGY (2007)
Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases
Nicole L. Webster et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis
Timothy A. Morris et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
T Lisman et al.
BLOOD (2005)
α2-Antiplasmin plays a significant role in acute pulmonary embolism
H Matsuno et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis
MH Meissner et al.
JOURNAL OF VASCULAR SURGERY (2002)
Recurrent venous thromboembolism after deep vein thrombosis -: Incidence and risk factors
PO Hansson et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice
DT Eitzman et al.
BLOOD (2000)
Share Paper
